From Hair to the Brain: The Short-Term Therapeutic Potential of Human Hair Follicle-Derived Stem Cells and Their Conditioned Medium in a Rat Model of Stroke

• Published in: Molecular neurobiology 2023-05, Vol.60 (5), p.2587-2601
• Main Authors: Karimi-Haghighi, Saeideh, Pandamooz, Sareh, Jurek, Benjamin, Fattahi, Sadegh, Safari, Anahid, Azarpira, Negar, Dianatpour, Mehdi, Hooshmandi, Etrat, Bayat, Mahnaz, Owjfard, Maryam, Zafarmand, Seyedeh Shaghayegh, Mostaghel, Mandana, Mousavi, Seyedeh Maryam, Jashire Nezhad, Nahid, Eraghi, Vida, Fadakar, Nima, Rahimi Jaberi, Abbas, Garcia-Esperon, Carlos, Spratt, Neil, Levi, Christopher, Salehi, Mohammad Saied, Borhani-Haghighi, Afshin
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animals; Biomedical and Life Sciences; Biomedicine; Brain - metabolism; Cell Biology; Cell therapy; Cerebral blood flow; Cerebral infarction; Culture Media, Conditioned - pharmacology; Disease Models, Animal; Follicles; Gene expression; Hair Follicle - metabolism; Humans; Infarction, Middle Cerebral Artery - drug therapy; Infarction, Middle Cerebral Artery - therapy; Ischemia; Ischemic Stroke - metabolism; Neurobiology; Neurology; Neurosciences; Rats; Reperfusion; Short term memory; Spatial memory; Stem cells; Stem Cells - metabolism; Stroke; Stroke - metabolism
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-023-03223-z

The short-term therapeutic impacts of stem cells and their derivatives were frequently reported in preclinical investigations of ischemic stroke (IS); however, several drawbacks including accessibility, abundancy, and ethical concerns limited their clinical application. We describe here for the first time the therapeutic potential of human hair follicle-derived stem cells (hHFSCs) and their conditioned medium (CM) in a rat model of IS. Furthermore, we hypothesized that a combination of cell therapy with repeated CM administration might enhance the restorative efficiency of this approach compared to each treatment alone. Middle cerebral artery occlusion was performed for 30 min to induce IS. Immediately after reperfusion, hHFSCs were transplanted through the intra-arterial route and/or hHFSC-CM administered intranasally. The neurological outcomes, short-term spatial working memory, and infarct size were evaluated. Furthermore, relative expression of seven target genes in three categories of neuronal markers, synaptic markers, and angiogenic markers was assessed. The hHFSCs and hHFSC-CM treatments improved neurological impairments and reduced infarct size in the IS rats. Moreover, molecular data elucidated that IS was accompanied by attenuation in the expression of neuronal and synaptic markers in the evaluated brain regions and the interventions rescued these expression changes. Although there was no considerable difference between hHFSCs and hHFSC-CM treatments in the improvement of neurological function and decrement of infarct size, combination therapy was more effective to reduce infarction and elevation of target gene expression especially in the hippocampus. These findings highlight the curative potential of hHFSCs and their CM in a rat model of IS. Graphical Abstract